ChatBot and Activity Monitoring in Patients Undergoing Chemoradiotherapy

Clinical trial NCT05318027 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05318027
Sponsor: Abramson Cancer Center at Penn Medicine
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Lung Cancer Gastrointestinal Cancer Head and Neck Cancer

Start date: 2023-05-22
Primary completion: 2026-12-01
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.